The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 1, 2006, Pages 136-143

  Niehaus, Angela ^a   Merrick, Gregory S ^a,e   Butler, Wayne M ^a   Wallner, Kent E ^b   Allen, Zachariah A ^a   Galbreath, Robert W ^a,c   Adamovich, Edward ^d  

^a WHEELING JESUIT UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c OHIO UNIVERSITY   (United States)

^d WHEELING HOSPITAL   (United States)

^e WHEELING HOSPITAL   (United States)

Author keywords

103Pd; 125I; Prostate brachytherapy; Prostate size; Urinary morbidity

Indexed keywords

DOSIMETRY; IMPLANTS (SURGICAL); PATIENT TREATMENT; REGRESSION ANALYSIS; SURGERY; TUMORS;

103PD; 125I; PROSTATE BRACHYTHERAPY; PROSTATE SIZE; URINARY MORBIDITY;

ISOTOPES;

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANDROGEN; IODINE 125; ISOTOPE; PALLADIUM 103;

AGED; ANDROGEN DEPRIVATION THERAPY; BLADDER NECK STENOSIS; BRACHYTHERAPY; CANCER STAGING; CATHETER; CONFERENCE PAPER; CONTROLLED STUDY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; ULTRASOUND;

AGED; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; LINEAR MODELS; MALE; PALLADIUM; PROSTATE; PROSTATIC NEOPLASMS; RADIOISOTOPES; URINARY BLADDER NECK OBSTRUCTION; URINARY CATHETERIZATION;

EID: 29244456745     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.06.035     Document Type: Conference Paper

References (19)

1. G.S. Merrick, K.E. Wallner, W.M. Butler Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland J Urol 169 2003 1643 1652
2. G.S. Merrick, K.E. Wallner, W.M. Butler Minimizing prostate brachytherapy-related morbidity Urology 62 2003 786 792
3. R.G. Stock, N.N. Stone, A. Tabert A dose-response study for I-125 prostate implants Int J Radiat Oncol Biol Phys 41 1998 101 108
4. G.S. Merrick, K.E. Wallner, W.M. Butler Patient selection for prostate brachytherapy More myth than fact Oncology 18 2004 445 452
5. D. Ash, A. Flynn, J. Battermann ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer Radiother Oncol 57 2000 315 321
6. I.D. Pedley Transperineal interstitial permanent prostate brachytherapy for carcinoma of the prostate Surg Oncol 11 2002 25 34
7. G.S. Merrick, W.M. Butler, J.H. Lief Temporal resolution of urinary morbidity following prostate brachytherapy Int J Radiat Oncol Biol Phys 47 2000 121 128
8. 3 Dosimetric analysis of implant quality Int J Radiat Oncol Biol Phys 46 2000 1199 1204
9. G.S. Merrick, W.M. Butler, K.E. Wallner Long-term urinary quality of life following permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 56 2003 454 461
10. T. Sherertz, K. Wallner, H. Wang Long-term urinary function after transperineal brachytherapy for patients with large prostate glands Int J Radiat Oncol Biol Phys 51 2001 1241 1245
11. N.N. Stone, R.G. Stock Long-term morbidity in patients treated with I-125 prostate brachytherapy followed a minimum of 4 years J Urol 171 2004 218 219
12. G.S. Merrick, W.M. Butler, W.H. Farthing The impact of Gleason score accuracy as a criterion for prostate brachytherapy patient selection J Brachyther Int 14 1998 112 121
13. G.S. Merrick, W.M. Butler Modified uniform seed loading for prostate brachytherapy Rationale, design and evaluation Tech Urol 6 2000 78 84
14. G.S. Merrick, W.M. Butler, A.T. Dorsey The effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation Tech Urol 7 2001 233 240
15. R. Nath, L.L. Anderson, G. Luxton Dosimetry of interstitial brachytherapy sources: Recommendations from the AAPM Radiation Therapy Committee Task Group No. 43 Med Phys 22 1995 209 234
16. M.J. Barry, W.O. Williford, Y. Chang Benign prostatic hyperplasia specific health status measures in clinical research How much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol 154 1995 1770 1774
17. D.Y. Gelblum, L. Potters, R. Ashley Urinary morbidity following ultrasound-guided transperineal prostate seed implantation Int J Radiat Oncol Biol Phys 45 1999 59 67
18. D.J. Schwartz, S.E. Schild, W.W. Wong Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy Int J Radiat Oncol Biol Phys 61 2005 60 63
19. Z.A. Allen, G.S. Merrick, W.M. Butler Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity Int J Radiat Oncol Biol Phys 62 2005 981 987